TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...
Space is part of Future US Inc, an international media group and leading digital publisher. Visit our corporate site.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results